The Pharma Career Ladder · The country manager · Step 4: Distributors and market access · Lesson 12

The advisory board worth holding

Real questions, documented, compliant

By Ahmed El Menshawy · 20 years in pharma, from medical rep to country manager in the UAE. Founder of RepPharma. LinkedIn
Published

An advisory board is one of the most useful meetings a company can hold. It is also one of the easiest to get wrong.

The test I use is simple: can we write down the question?

A genuine advisory board starts with something the company needs to understand. How specialists see an unmet need. What a new indication means in local practice. What is missing from the information patients receive. If we cannot write that question down, we do not need the board.

The difference shows in four places.

  • The reason. A documented question, not budget left before year end.
  • Who is invited. Experts chosen for what the question needs, and only as many as it needs. Not the highest prescribers.
  • The fee. Fair market value, under a written contract, for real work.
  • The output. Written advice, reviewed and acted on. Not photos from a dinner.

And the roles are clear. Medical leads it. Compliance approves it. Sales does not choose the advisers, and there is never any link to prescribing.

Done this way, an advisory board is worth every hour. Done the other way, it is an inducement with an agenda.

“If you cannot write down the question, you do not need the board.”
The advisory board worth holding: Real questions, documented, compliant

Lesson 12 of 17 in Step 4: Distributors and market access, with the full guide and a checklist for this week.

More lessons in step 4: Distributors and market access

Distributors and market access, in RepPharma

Targets split by rep, product and month

Yearly targets are split by rep, product and month, and sales credit can be moved between reps without changing the company total.

Distributor stock and sell-out

Distributor stock and pharmacy sell-out side by side, with short-expiry lots flagged up to 90 days ahead.

One system for the whole field force

Visits, plans, forecasts, samples, expenses, leaves and approvals, with role-based access from rep to country manager.

A new step every week in the Pharma Career Ladder newsletter on LinkedIn.